Over the past 75 years, researchers in digestive diseases at the University of Chicago have made crucial advances in the understanding of clinical disease behavior and progression, therapeutic efficacy, disease monitoring, cost-effectiveness assessment, genetics of IBD, epigenetics of IBD, microbial influences on gastrointestinal function, immune mechanisms, normal physiology and pathogenesis of luminal diseases. The investigators in the DDRCC have increasingly recognized that a comprehensive understanding of the clinical behavior, phenotype, epidemiology and pathophysiology of human disease requires the analysis of clinical data, analysis of human cells and tissues and the establishment/advancement of human model systems and cellular experiments. The ITR core was created to enable translational research by providing the infrastructure and means to integrate clinical information with experimental data relating to the microbiota, the intestinal tissue, the immune system and the genetic and epigenetic make-up. The ITR Core has the singular goal of establishing a centralized service to provide consultative and hands-on technical expertise to conduct associated human studies, key clinical database information that could be used for clinical trials recruitment, outcomes analysis, therapeutic efficacy studies, and in conjunction with biospecimen recruitment, a source of well-phenotyped samples as reagents for basic science and translational research.
The Specific Aims of the ITR Core are summarized as follows: (1) to provide services for human biospecimen-based study design and cellular analysis; (2) to provide the infrastructure and services to optimize clinical database utilization and (3) to provide the infrastructure and services to optimize human biospecimen utilization. In particular, the ITR Core has worked steadfastly to optimize consultation services for human study design, create a dynamic mechanism to access and assess clinical data and to create an efficient workflow for patient and biospecimen recruitment. All improvements have been integrally supported by the University of Chicago and collaborative resources to address the needs of DDRCC investigators and to create an ITR Core that functions as a critical resource for the other DDRCC Cores. Since September 1, 2009, 27 DDRCC members (53% of membership) have utilized the ITR Core and 2568 Genesys IBD Registry and 603 Celiac Disease Registry patients have been recruited, with a total of 4477 patient recruited through the ITR Core for all GI studies in the past 5 years. The ITR Core has also built a repository of biospecimens to facilitate the rapid generation of data which includes 16,291 biospecimens on 1002 patients, including whole blood DNA, serum, biopsy RNA, biopsy DNA, flash frozen biopsy samples and FFPE tissues. The ITR core will continue to build on the infrastructural foundation established over the last 4 years to meet the growing and changing needs of DDRCC investigators for clinical database information and well-phenotyped biospecimens. The ultimate goal of the ITR Core is to remain an integral, essential resource for the advancement of research in understanding human physiology, human digestive disease pathogenesis and future therapeutic development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK042086-28
Application #
9393989
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
28
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Cockrell, Chase; An, Gary (2017) Sepsis reconsidered: Identifying novel metrics for behavioral landscape characterization with a high-performance computing implementation of an agent-based model. J Theor Biol 430:157-168
Pekow, Joel; Meckel, Katherine; Dougherty, Urszula et al. (2017) miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Clin Cancer Res 23:5281-5291
Messer, Jeannette S (2017) The cellular autophagy/apoptosis checkpoint during inflammation. Cell Mol Life Sci 74:1281-1296
An, G; Fitzpatrick, B G; Christley, S et al. (2017) Optimization and Control of Agent-Based Models in Biology: A Perspective. Bull Math Biol 79:63-87
Arvans, Donna; Jung, Yong-Chul; Antonopoulos, Dionysios et al. (2017) Oxalobacter formigenes-Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells. J Am Soc Nephrol 28:876-887
Nobutani, Kentaro; Miyoshi, Jun; Musch, Mark W et al. (2017) Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawal. Pharmacol Res Perspect 5:
Messer, J S; Liechty, E R; Vogel, O A et al. (2017) Evolutionary and ecological forces that shape the bacterial communities of the human gut. Mucosal Immunol 10:567-579
Nie, Litong; Shuai, Lin; Zhu, Mingrui et al. (2017) The Landscape of Histone Modifications in a High-Fat Diet-Induced Obese (DIO) Mouse Model. Mol Cell Proteomics 16:1324-1334
Denzin, Lisa K; Khan, Aly A; Virdis, Francesca et al. (2017) Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob. Immunity 47:310-322.e7
Miyoshi, Jun; Bobe, Alexandria M; Miyoshi, Sawako et al. (2017) Peripartum Antibiotics Promote Gut Dysbiosis, Loss of Immune Tolerance, and Inflammatory Bowel Disease in Genetically Prone Offspring. Cell Rep 20:491-504

Showing the most recent 10 out of 633 publications